F. Carvalho

Rationale and Design of the VITALITY-HFpEF Trial.

Sanjiv J. Shah, P. Ponikowski, S. Solomon, 2019, Circulation. Heart failure.

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

J. Barberà, S. Rosenkranz, G. Simonneau, 2017, BMC Pulmonary Medicine.

Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial.

Sanjiv J. Shah, P. Ponikowski, S. Solomon, 2020, JAMA.

The VITALITY-HFpEF trial ( Evaluate the Efficacy and Safety of the Oral sGC Stimulator Vericiguat to Improve Physical Functioning in Daily Living Activities of Patients With Heart

Sanjiv J. Shah, P. Ponikowski, S. Solomon, 2019 .